In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other best value dividend stocks. Dividends, though sometimes underappreciated, have ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Shares of McKesson Corp. MCK rose 2.90% to $671.76 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 ...

has completed the sale of a controlling stake in New Jersey’s Prism Vision Holdings LLC to Fortune 500 pharma and medical supply company McKesson Corp. for about $850 million. Irving ...

In the latest trading session, McKesson (MCK) closed at $652.83, marking a -1.38% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.57%. At the same time ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

Quad-C Management has sold its stake in Prism Vision, a New Providence, New Jersey-based provider of general ophthalmology and retina management services, to McKesson Corporation. No financial ...

85.07% of the stock is owned by institutional investors. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S ...

("Quad-C"), a leading middle market private equity firm, has completed the sale of its interest in PRISM Vision Holdings, LLC ("PRISM Vision") to McKesson Corporation. PRISM Vision is a provider ...